National Institute for Health and Care Excellence

Quality statement 3: Panel germline genetic testing for non-mucinous high-grade epithelial ovarian cancer

Germline genetic testing identifies pathogenic variants present at birth that increase the risk of developing ovarian cancer. It also identifies the risk of developing other cancers and, for adults ...
Pharm Exec

Screening for DPYD: Q&A with Kristine Ashcraft

The YouScript CEO discusses new FDA guidance. FDA recently announced new safety requirements for DPD screening in cancer patients. Kristine Ashcraft, founder and CEO of YouScript, spoke with ...
Pharmabiz

Ambry Genetics introduces new epilepsy genetic testing panels

Ambry Genetics (Ambry), a leader in clinical genetic diagnostics and genetics software solutions, announced that it is launching a new suite of seven genetic testing panels for epilepsy. Tests can be ...
Healio

Respiratory viral panel lowers antibiotic use duration in ventilated patients

Please provide your email address to receive an email when new articles are posted on . Adopting respiratory viral panel testing led to shorter antibiotic usage and a lower risk for C. difficile ...
Business Wire

New Data Show Delve Bio’s Metagenomic Testing Delivers Broader, Deeper Pathogen Identification Compared to Traditional Testing

BOSTON--(BUSINESS WIRE)--Delve Bio, a pioneer in metagenomic next-generation sequencing (mNGS) for infectious diseases, today announced data presented at the American Society for Microbiology (ASM) ...